This test is most useful if any of these apply to you.
If you have hay fever, you already know that not all pollen allergies behave the same way. Some people sneeze through grass season and recover. Others develop asthma, react to multiple pollens, and have symptoms that worsen over years. Phl p 7 IgE (immunoglobulin E to timothy grass component Phl p 7) helps explain which group you may fall into.
This is a niche but informative test within component-resolved allergy diagnostics (CRD), a newer approach that measures your immune reaction to individual allergen molecules rather than to a whole pollen extract. A positive Phl p 7 result is uncommon, but when it appears, it signals something specific about how broadly your immune system is reacting.
Phl p 7 (Phleum pratense allergen 7) is a small calcium-binding protein found in timothy grass pollen. It belongs to a family of molecules scientists call polcalcins, which appear in many different pollens (birch, olive, mugwort, ragweed, and more). Because the same family of molecules shows up across unrelated plants, your immune system can react to all of them once it learns to recognize one.
This test measures IgE antibodies in your blood that bind specifically to Phl p 7. IgE is the antibody class that drives allergic reactions; it is made by your immune cells in lymph tissue and circulates in blood, where it primes the cells that release histamine when you encounter the allergen. A positive result means your body has been sensitized to this specific molecule. It does not on its own predict how severe your symptoms will be, but it does say something important about the pattern of your allergy.
Phl p 7 sensitization is relatively rare. In a European study of 77 grass-allergic adults, only 7.8% had IgE to Phl p 7. In a large pediatric cohort of 1,120 children with grass pollen seasonal allergic rhinitis, only a small subset were sensitized to Phl p 7. In a study of timothy-sensitized people in northern China, only about 3% had Phl p 7 IgE.
When it does appear, it usually shows up late in the evolution of an allergy, after you have already developed IgE to the more common grass components like Phl p 1 and Phl p 5. It marks a pattern called polysensitization, where the immune system has expanded its reactivity to multiple allergen molecules over time, often years.
This is one of the most clinically meaningful associations. In the 1,120-child pediatric cohort, Phl p 7 IgE was linked to asthma and to highly complex IgE profiles (people sensitized to many different allergen molecules, with high total IgE). The link is likely a proxy for overall atopic burden rather than a direct cause: people whose immune systems are broadly reactive to many pollens tend to develop asthma more often than those with narrower allergies. Either way, if you have a positive Phl p 7, your risk of having or developing asthma alongside your rhinitis may be higher.
Polcalcins like Phl p 7 are highly cross-reactive. IgE to Phl p 7 typically tracks closely with IgE to Bet v 4 (the equivalent polcalcin in birch pollen) and to similar molecules in other plants. If you are positive for Phl p 7, the implication is that some of your apparent grass, tree, or weed allergies may not reflect true independent sensitizations to each plant. Instead, they may reflect one underlying reaction to a shared family of molecules carried across many pollens.
This matters for treatment. Allergen immunotherapy works best when targeted at the molecules driving genuine sensitization (mainly Phl p 1, Phl p 5, and a few others for grass). If your reactivity is mostly to polcalcins like Phl p 7, standard immunotherapy may be less likely to deliver a strong benefit. A positive Phl p 7 is one of several signals that an allergist may use to decide whether immunotherapy is right for you and which extract to use.
Beyond asthma, Phl p 7 sensitization tracks with more severe and complex disease overall. In children with seasonal grass rhinitis, the presence of Phl p 7 IgE was associated with very complex IgE profiles (many molecules, high total IgE) and more difficult-to-manage allergy. In atopic dermatitis studies using broad allergen panels, very high IgE levels to multiple components clustered with more severe skin disease, asthma, and rhinitis.
None of this means a single positive result is a diagnosis on its own. But it tells you that your allergy is unlikely to be a simple grass-only reaction and that you may benefit from a broader workup.
A standard allergy panel typically uses whole-pollen extracts or the most common single molecules like Phl p 1. These are excellent for confirming that you are sensitized to grass. They will not tell you whether your sensitization is narrow (just genuine grass allergy) or wide (a cross-reactive polcalcin pattern that touches many pollens).
Phl p 7 fills that gap. It is best ordered as part of a broader component panel that also includes Phl p 1, Phl p 5, and often Phl p 12 (profilin, another cross-reactive molecule). The combination reveals whether your grass allergy is genuine, cross-reactive, or both.
| What You Want To Know | Which Component Tells You |
|---|---|
| Genuine grass pollen allergy | Phl p 1, Phl p 5 |
| Pollen-to-pollen cross-reactivity | Phl p 7, Phl p 12 |
| Risk of asthma with rhinitis | Phl p 7 (when positive) |
What this means for you: a positive Phl p 1 with a negative Phl p 7 suggests a true, focused grass allergy. A positive Phl p 7 with positive results across multiple pollen components suggests broader cross-reactivity that may need a different management approach.
A single Phl p 7 result is a snapshot, not a verdict. IgE profiles evolve, especially in children and adolescents, and Phl p 7 sensitization typically appears late in that evolution. If you are negative now, that does not guarantee you always will be. If you are positive, the level can shift modestly over time with exposure and treatment.
The most useful approach is to get a baseline, especially if you have hay fever symptoms that are getting worse, expanding to new triggers, or accompanied by wheezing. Retest in 6 to 12 months if you are starting immunotherapy or making other major changes to your allergy management, and at least every couple of years thereafter to watch for new sensitizations. Trends matter more than any single number, because Phl p 7 levels alone do not map cleanly to symptom severity.
A positive Phl p 7 should prompt three things. First, a broader component-resolved panel if you have not already done one, ideally including Phl p 1, Phl p 5, Phl p 12, and components from other pollens you may encounter (birch Bet v 1 and Bet v 4, mugwort, ragweed, olive). This maps the full shape of your sensitization.
Second, an honest conversation with an allergist before starting immunotherapy. The presence of polcalcin sensitization can change which extract is appropriate and how likely you are to benefit. Third, attention to your airway. Because Phl p 7 tracks with asthma risk, ask about lung function testing (spirometry) if you have any history of wheezing, exercise-induced cough, or nighttime breathing issues, even if mild.
Allergen-specific IgE tests are generally stable, but a few situations can shift interpretation. Recent intense allergen exposure (a heavy pollen day, for example) can transiently boost IgE levels. Active treatment with omalizumab (an anti-IgE biologic for severe allergy or asthma) can interfere with some specific IgE measurements. Component tests rely on the quality of the specific allergen used; different lab platforms can give numerically different results for the same sample, so trend-tracking is most reliable when done at the same lab.
A positive Phl p 7 IgE does not by itself diagnose any allergic disease. It is a sensitization marker. The clinical meaning emerges only when you combine it with your symptoms, exposure history, and other component results.
Evidence-backed interventions that affect your Timothy Grass (Phl p 7) IgE level
Timothy Grass (Phl p 7) IgE is best interpreted alongside these tests.